Web
|
Images
|
News
News Home
US
World
Business
Finance
Industry
Technology
Science
Media & Advertising
Politics/Law
Entertainment
Internet
Health
Sports
Culture
WORLD
Log In
Sunesis' Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia
Have an interest in this Story?
Sign Up for Real-Time email updates
Pharma Live
|
November 05, 2009
SOUTH SAN FRANCISCO, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. ( NASDAQ:SNSS) today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two P...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Log in
|
Register
Most Read World Articles
Dogs get free flight to New York
- Chicago Tribune
Headley my half brother: Pakistani PM's PRO
- Topnews.in
Gate crashers met Obama at state dinner with India
- Mail & Guardian Online
"+ "Japan launches spy satellite
- Straits Times
Hatoyama's former aide questioned
- Asahi.com
Featured Members
Mark Palmer
Founder
Internet consultancies
David Hood
Director
Marketing/Public Relations
View more profiles
Access dozens of premium and subscriptions sites
Free!
Download now
.
Advertise
|
Build a News Circle
|
Get News Briefings
|
Congoo News Home
|
Get the Netpass
About Congoo
|
Terms
|
Privacy
|
Need Help?
|
Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.